Molecular structure of Kynuramine dihydrobromide, CAS Number: 304-47-2
Kynuramine dihydrobromide (CAS 304-47-2)
See product citations (3)
Alternate Names:
3-(2-Aminophenyl)-3-oxopropanamine
Application:
Kynuramine dihydrobromide is a substrate for monoamine oxidase
CAS Number:
304-47-2
Purity:
≥97%
Molecular Weight:
326.03
Molecular Formula:
C9H12N2O•2HBr
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Product Citations
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Kynuramine dihydrobromide is a chemical compound that belongs to the class of tryptamine derivatives. It is a derivative of the neurotransmitter serotonin. Kynuramine dihydrobromide is a substrate of the enzyme monoamine oxidase (MAO). MAO is responsible for the metabolism and breakdown of various monoamine neurotransmitters, including serotonin. Kynuramine dihydrobromide can be metabolized by MAO, leading to the production of various metabolites.
Kynuramine dihydrobromide (CAS 304-47-2) References
- Chronic dietary mercury exposure causes oxidative stress, brain lesions, and altered behaviour in Atlantic salmon (Salmo salar) parr. | Berntssen, MH., et al. 2003. Aquat Toxicol. 65: 55-72. PMID: 12932701
- The effects of curcumin on depressive-like behaviors in mice. | Xu, Y., et al. 2005. Eur J Pharmacol. 518: 40-6. PMID: 15987635
- Antidepressant-like effect of low molecular proanthocyanidin in mice: involvement of monoaminergic system. | Xu, Y., et al. 2010. Pharmacol Biochem Behav. 94: 447-53. PMID: 19857512
- Evidence for the involvement of the noradrenergic system, dopaminergic and imidazoline receptors in the antidepressant-like effect of tramadol in mice. | Jesse, CR., et al. 2010. Pharmacol Biochem Behav. 95: 344-50. PMID: 20184917
- Purification and immunochemical interrelationship of cytosolic and mitochondrial monoamine oxidase from rat brain. | Azam, M. and Baquer, NZ. 1989. Neurochem Int. 14: 321-6. PMID: 20504432
- The interactions of caffeine with monoamine oxidase. | Petzer, A., et al. 2013. Life Sci. 93: 283-7. PMID: 23850513
- Piperine potentiates the antidepressant-like effect of trans-resveratrol: involvement of monoaminergic system. | Huang, W., et al. 2013. Metab Brain Dis. 28: 585-95. PMID: 23943324
- Azure B and a synthetic structural analogue of methylene blue, ethylthioninium chloride, present with antidepressant-like properties. | Delport, A., et al. 2014. Life Sci. 117: 56-66. PMID: 25445435
- Antidepressant-like effects of ferulic acid: involvement of serotonergic and norepinergic systems. | Chen, J., et al. 2015. Metab Brain Dis. 30: 129-36. PMID: 25483788
- 4-Organoseleno-Isoquinolines Selectively and Reversibly Inhibit the Cerebral Monoamine Oxidase B Activity. | Sampaio, TB., et al. 2016. J Mol Neurosci. 59: 135-45. PMID: 27052821
- Interactions of endocannabinoid virodhamine and related analogs with human monoamine oxidase-A and -B. | Pandey, P., et al. 2018. Biochem Pharmacol. 155: 82-91. PMID: 29958841
- Activation of monoaminergic system contributes to the antidepressant- and anxiolytic-like effects of J147. | Pan, X., et al. 2021. Behav Brain Res. 411: 113374. PMID: 34023306
- Modulation of monoamine oxidase activity in different brain regions and platelets following exposure of rats to methylmercury. | Chakrabarti, SK., et al. 1998. Neurotoxicol Teratol. 20: 161-8. PMID: 9536461
- Increase of striatal dopamine release by cadmium in nursing rats and its prevention by dexamethasone-induced metallothionein. | Gutiérrez-Reyes, EY., et al. 1998. Toxicology. 131: 145-54. PMID: 9928629
Substrate of:
MAO.Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Kynuramine dihydrobromide, 25 mg | sc-207782 | 25 mg | $127.00 | |||
Kynuramine dihydrobromide, 100 mg | sc-207782A | 100 mg | $312.00 | |||
Kynuramine dihydrobromide, 250 mg | sc-207782B | 250 mg | $597.00 |